The PBMC multi-modal assessment method has broad applicability across human medicine and veterinary practice, wherever chronic environmental toxin exposure is suspected as a contributing factor to disease.
Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) encompasses a spectrum of immune-mediated conditions triggered by environmental adjuvants including silicones, heavy metals, and other toxins. The multi-modal PBMC assessment provides direct evidence of the specific triggering agent and the degree of immune cell dysfunction, enabling targeted treatment.
Breast Implant Illness is a constellation of systemic symptoms attributed to silicone breast implants. PBMC-based HRMS can detect silicone oligomers and siloxane monomers that have migrated from the implant into the systemic circulation and accumulated in immune cells, providing objective evidence of exposure.
Chronic exposure to heavy metals (lead, mercury, arsenic) and persistent organic pollutants has been linked to an increased risk of Parkinson's disease, Alzheimer's disease, and ALS. PBMC-based testing provides a non-invasive window into the cumulative neurotoxic burden that may be contributing to neurodegeneration.
Chronic Inflammatory Response Syndrome (CIRS) and mold-related illness arise from prolonged inhalation of mycotoxins, mold fragments, and other biotoxins in water-damaged or damp indoor environments. Occupants of buildings with active mold growth — particularly Stachybotrys chartarum (black mold), Aspergillus, and Penicillium species — inhale aerosolized mycotoxins that are absorbed systemically and accumulate in PBMCs. Conventional urine or serum testing frequently misses this intracellular burden. PBMC-based HRMS provides direct evidence of systemic mycotoxin absorption from inhalation, while EIS quantifies the resulting immune cell dysfunction. This combination is uniquely suited to objectively confirm WDB exposure in patients with unexplained multi-symptom illness, brain fog, fatigue, and immune dysregulation.
Conditions such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Gulf War Illness, and mold-related illness often involve complex, multi-toxin exposures. The comprehensive HRMS panel can identify the specific toxin or combination of toxins driving immune dysfunction, while EIS quantifies the resulting cellular damage.
Dogs and cats are exposed to many of the same environmental toxins as their owners, often at higher concentrations due to floor-level exposure and grooming behaviors. PBMC-based testing in companion animals can identify toxin burdens from contaminated food, water, household products, and lawn treatments.
Mycotoxin contamination of animal feed is a major cause of reduced productivity, immune suppression, and mortality in livestock. PBMC-based testing in dairy cattle, poultry, and swine can detect aflatoxin B1, ochratoxin A, and other mycotoxins before clinical signs appear, enabling early feed intervention and protecting the food supply.